{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-010552","form_type":"8-K","ticker":null,"cik":"0001411906","company_name":"Ampio Pharmaceuticals, Inc.","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.767910+00:00","generated_at":"2026-06-14T12:44:42.790129+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ampio declares Series D Preferred stock dividend with super voting rights tied to reverse split","bullets":["Board declared a dividend of 1/1000th share of Series D Preferred per common share; record date June 8, 2023.","Each share of Series D Preferred has 1,000,000 votes, but only on reverse stock split proposals; vote mirrors common vote.","Shares not present at reverse-split meeting automatically redeemed for $0.01 per 10 shares if certain conditions met.","Bylaws amended to reduce quorum at stockholder meetings from majority to one-third of outstanding shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-010552","json":"https://secwatch.observer/filing/0001558370-23-010552.json","markdown":"https://secwatch.observer/filing/0001558370-23-010552.md","text":"https://secwatch.observer/filing/0001558370-23-010552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/0001558370-23-010552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/ampe-20230524x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T12:44:42.790129+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"280d1620d541d7acf0c8109c53fb1e918574d397","claim":"Ampio Pharmaceuticals, Inc.: Amended bylaws to change quorum requirement at stockholder meetings from a majority to one-third of outstanding shares (effective 2023-05-24).","evidence_excerpt":"On May 24, 2023, the board of directors the (“Board”) of Ampio Pharmaceuticals, Inc. (the “Company”), adopted and approved an amendment to the Company’s Amended and Restated Bylaws (the “ Bylaws Amendment ”) in order to change the proportion of shares present required to constitute a quorum at a meeting of stockholders, from a majority to one-third of the outstanding shares of stock entitled to vote.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/0001558370-23-010552-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-05-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}